NCT00250393View on ClinicalTrials.gov

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Parkinson's Disease
Interventions
DRUG

Istradefylline (KW-6002)

Trial Locations (1)

Unknown

Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00250393 - A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter